Prostate Cancer information and treatment options at HIFU center México

HIFU Treatment with Sonablate® 500
Overview \| History \| How it Works \| Benefits \| Treatment Process \| FAQ

HIFU, which is short for High Intensity Focused Ultrasound, is a state-of-the-art technology acoustic ablation technique that utilizes the power of ultrasound to destroy deep-seated tissue

with pinpoint accuracy for treatment of Prostate cancer. HIFU focuses sound waves in a targeted area which rapidly increases the temperature in the focal zone causing tissue destruction.

The control and precision of HIFU reduces the risk of common side effects such as impotence and incontinence. HIFU is a 2-3 hour, one-time procedure performed on an out-patient basis under spinal or epidural anesthesia. Unlike radiation, HIFU is non-ionizing so it can be repeated if necessary without damaging healthy tissue. This means that HIFU can also be used as a salvage technique if other prostate cancer treatments fail.

HIFU is: NON INVASIVE :: PAINLESS :: REQUIRES NO INCISION :: EFFECTIVE :: NO BLOOD LOSS :: NERVE SPARING

HIFU Sonablate® 500 Highlights

HIFU (High Intensity Focused Ultrasound) with the Sonablate® 500 is a non invasive acoustic ablation technique.
Acoustic ablation uses intersecting, precision-focused ultrasound waves to raise the temperature of the target tissue to more than 80 to 90 degrees Celsius in two to three seconds, effectively destroying the tissue.
Ultrasound energy is non-ionizing “clean energy” that does not affect tissue surrounding the target zone, as opposed to radiation therapies.
In approved countries, HIFU can be given in one to three hours on an outpatient basis with epidural anesthesia. HIFU is being studied around the world to treat all types of cancer and soft tissue diseases

About the Sonablate® 500

The Sonablate® 500 is approved in many countries outside the U.S. as an image-guided acoustic ablation device developed by Focus Surgery, Inc. for prostate disease therapy..
The technology behind the device originated at the Indiana University School of Medicine in Indianapolis in the 1970s. It was further developed in leading research centers across the globe..
In 2001, The Sonablate® 500 received its CE Mark for European distribution and its MHW approval for Japan. It is also approved for use here in México, Canada, China, Australia, Japan, Costa Rica, South Africa and the Caribbean.
Recent studies in Europe have shown promising results five years following treatment with a lower incidence of erectile dysfunction and urinary incontinence than reported in studies of other therapies.
In countries where it is approved, the Sonablate® 500 allows a trained urologist to visualize the prostate and plan and monitor the therapy in real time, ensuring maximum precision, flexibility, safety and control for the clinician.

Potential Side Effects

All Prostate cancer treatments have potential side effects. However, HIFU with Sonablate® 500 greatly reduces the chance for complications and side effects. Click here to learn more.

Visit www.focus-surgery.com for an in-depth explanation of how the Sonablate® 500 works, the history of the technology and the physicians who have performed HIFU with the SB-500.

Return to top